Skip to content

    AGIOS PHARMACEUTICALS (AGIO) stock price & financials

    View AGIO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance15.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $8.96M
    $10.73M
    $8.73M
    $12.46M
    $12.88M
    +43.7%
    $19.97M
    +86.1%
    $20.75M
    +137.7%
    $44.74M
    +259.3%
    Strengthening
    Operating Profit
    -$102.81M
    -$125.04M
    -$106.63M
    -$127.06M
    -$116.87M
    -13.7%
    -$121.58M
    +2.8%
    -$110.03M
    -3.2%
    -$110.55M
    +13.0%
    Strengthening
    Net Profit
    $947.91M
    -$96.52M
    -$89.29M
    -$112.02M
    -$103.43M
    -110.9%
    -$108.04M
    -11.9%
    -$99.11M
    -11.0%
    -$100.70M
    +10.1%
    Weakening
    EPS
    $16.65
    $-1.55
    $-1.93
    $-1.78
    -110.7%
    $-1.69
    -9.0%
    $-1.69
    +12.4%
    Stable
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $1.00B
    -$103.43M
    -110.3%
    MarginsOPM
    -1146.9%
    -1165.3%
    -1222.0%
    -1020.1%
    -907.4%
    +20.9%
    -608.9%
    +47.7%
    -530.3%
    +56.6%
    -247.1%
    +75.8%
    Strengthening
    Tax
    5.3%
    0.0%
    -100.0%
    ReturnsROIC
    -124.5%
    12.7%
    11.7%
    14.7%
    13.6%
    14.2%
    +11.9%
    13.0%
    +11.0%
    13.2%
    -10.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$70.50M$80.93M$127.44M$203.13M$139.26M$88.20M$76.25M$89.13M$99.65M
    Short-Term Investments
    Total Current Assets$613.78M$611.70M$636.68M$1.06B$832.77M$833.84M$965.60M$942.05M$717.67M
    Net PP&E$24.32M$125.11M$115.48M$104.05M$88.12M$69.79M$54.55M$41.23M$33.82M
    Goodwill
    Intangibles
    Total Assets$858.46M$890.74M$852.95M$1.44B$1.24B$937.12M$1.66B$1.30B$1.11B
    LiabilitiesTotal Current Liabilities$93.50M$92.89M$94.39M$59.83M$62.63M$67.95M$81.16M$82.21M$70.22M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$106.07M$97.46M$85.66M$72.00M$56.99M$40.21M$21.82M$11.95M
    Total Liabilities$170.92M$250.21M$453.45M$145.76M$137.90M$126.10M$122.24M$104.11M$82.40M
    EquityCommon Stock & APIC$58.0K$68.0K$69.0K$71.0K
    Retained Earnings-$1.10B-$1.52B-$1.84B-$238.76M-$470.56M-$822.65M-$148.92M-$561.71M-$761.52M
    Total Equity$687.54M$640.53M$399.50M$1.29B$1.10B$811.02M$1.54B$1.19B$1.03B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$304.42M-$370.62M-$290.76M-$407.32M-$309.48M-$296.06M-$389.84M-$372.98M-$360.60M
    Cash from Investing-$273.82M$91.44M$75.75M$1.25B$243.26M$239.57M$363.44M$377.18M$367.15M
    Cash from Financing$546.02M$289.61M$261.52M-$765.77M$2.35M$5.43M$14.44M$8.68M$12.22M
    SummaryCapital Expenditure-$6.99M-$12.03M-$14.11M-$5.74M-$4.88M-$999.0K-$1.69M-$4.32M-$4.66M
    Free Cash Flow-$311.41M-$382.65M-$304.87M-$413.06M-$314.36M-$297.06M-$391.53M-$377.29M-$365.25M
    FCF Margin-329.9%-324.5%-2207.6%-1107.5%-1072.7%-698.3%-371.4%

    Ratios